From Acute to Chronic Postoperative Pain in Patients for Elective Cholecystectomy. Immunological Tests
NCT ID: NCT01546480
Last Updated: 2014-06-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
18 participants
OBSERVATIONAL
2011-11-30
2014-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of the study is to measure inflammatory factors in cerebrospinal fluid and blod at patients 12 months after the operation.
DNA-samples are collected to examine genetical factors, important for perception of pain, and the development of chronic pain.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
From ACute To Chronic Postoperative Pain in Patients for Elective Cholecystectomy
NCT01553253
Relationship Between Acute Phase Markers and Post-operative Pain in Laparoscopic Cholecystectomy: An Observational Study
NCT06375057
Association of Preoperative Pain With Moderate to Severe Acute Pain After Laparoscopic Cholecystectomy.
NCT05543668
Are Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Systemic Immune Inflammation Score Values Indicators for Postoperative Pain?
NCT05558553
The Effect of Transvaginal vs. Conventional Laparoscopic Cholecystectomy on the Postoperative Course
NCT01552421
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pain patients
Patients with unexplained chronic abdominal pain 12 months after elective cholecystectomy
No interventions assigned to this group
Operated painfree Patients
Painfree patients 12 months after elective cholecystectomy
No interventions assigned to this group
Nonoperated painfree patients
Painfree patients with no previous abdominal operation
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No pain 12 months after elective cholecystectomy
* Elective operation in spinal anesthesia or
* Or healthy volunteers accepting samples of blod, cerebral spinal fluid and saliva, to be collected
Exclusion Criteria
* Anticoagulant treatment
Group 2:
* Immunosuppressive treatment (NSAID excepted)
* Anticoagulant treatment
Group 3:
* Acute or chronic pain condition
* Immunosuppressive treatment (NSAID excepted)
* Previous abdominal operation
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vejle Hospital
OTHER
Oberstinde Kirsten Jensa la Cours Foundation
OTHER
Odense University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Morten Rune Eckhardt
Afdelingslæge
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Odense University Hospital
Odense, , Denmark
Lillebælt Hospital
Vejle, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
119
Identifier Type: OTHER
Identifier Source: secondary_id
ImmT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.